Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-012326
Date:2021-02-18
Issuer: FATE THERAPEUTICS INC (FATE)
Original Submission Date:

Reporting Person:

WOLCHKO J SCOTT
C/O FATE THERAPEUTICS, INC.;
3535 GENERAL ATOMICS COURT #200 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-02-18 M 20,000 a $6.62 413,793 direct
COMMON STOCK 2021-02-18 S 1,401 d $99.08 412,392 direct
COMMON STOCK 2021-02-18 S 1,848 d $100.48 410,544 direct
COMMON STOCK 2021-02-18 S 2,602 d $101.42 407,942 direct
COMMON STOCK 2021-02-18 S 8,602 d $102.26 399,340 direct
COMMON STOCK 2021-02-18 S 5,547 d $103.16 393,793 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.62 2021-02-18 deemed execution date M 20,000 (d) 2024-01-08 common stock 20,000 $6.62 14,846 direct
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 10, 2020.
f2 represents the weighted average sale price of the shares sold ranging from $98.65 to $99.645 per share. the reporting person will provide, upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
f3 represents the weighted average sale price of the shares sold ranging from $99.825 to $100.81 per share. the reporting person will provide, upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
f4 represents the weighted average sale price of the shares sold ranging from $100.83 to $101.82 per share. the reporting person will provide, upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
f5 represents the weighted average sale price of the shares sold ranging from $101.85 to $102.84 per share. the reporting person will provide, upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
f6 represents the weighted average sale price of the shares sold ranging from $102.86 to $103.66 per share. the reporting person will provide, upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
f7 this option is fully vested.
f8 not applicable.
WhaleWisdom Logo

Elevate your investments